Facial nevus depigmentosus getting remarkable repigmentation by treatment with a 308-nm excimer laser: A case report

2018 ◽  
Vol 31 (5) ◽  
pp. e12662 ◽  
Author(s):  
Qinghai Zeng ◽  
Qi Shi ◽  
Jinhua Huang ◽  
Jian Huang ◽  
Zhen Tang ◽  
...  
Keyword(s):  
2022 ◽  
Vol 13 (e) ◽  
pp. e5-e5
Author(s):  
Catarina Queirós ◽  
Luís Uva ◽  
Paulo Filipe

In the last two decades, 308-nm excimer laser has been increasingly recognized as a therapeutic alternative for several dermatological conditions, being currently FDA approved for the treatment of localized vitiligo and moderately severe localized psoriasis unresponsive to topical treatments. We describe the case of a 17-year-old with a recalcitrant form of dermatitis occupying the entire perioral region, previously unresponsive to several treatments, who was treated with 308-nm excimer laser with an excellent result. 308-nm monochromatic excimer laser has several advantages over other types of phototherapy, including lower UV dose exposure, shorter courses of therapy and a better sparing of adjacent tissue. Although infrequently used, 308-nm excimer laser certainly has a vast potential in Dermatology, particularly regarding recalcitrant and localized inflammatory conditions, such as the one we present.


2021 ◽  
Vol 9 (34) ◽  
pp. 10666-10670
Author(s):  
Fang-Jie Hou ◽  
Xiao-Teng Ma ◽  
Yu-Jie Zhou ◽  
Jun Guan

Eye ◽  
1994 ◽  
Vol 8 (4) ◽  
pp. 481-482 ◽  
Author(s):  
R Sampath ◽  
A E A Ridgway ◽  
B Leatherbarrow

1992 ◽  
Vol 27 (2) ◽  
pp. 122-124 ◽  
Author(s):  
Melitta B. Preisack ◽  
Wolfram Voelker ◽  
Karl K. Haase ◽  
Karl R. Karsch

2019 ◽  
Vol 10 (3) ◽  
pp. 251-253
Author(s):  
Andrew M. Armenta ◽  
Krystal M. Jones ◽  
Jason S. Reichenberg

Introduction: Mycosis fungoides (MF), a type of cutaneous T-cell lymphoma, is a rare condition with a variety of treatment options. A frequently utilized method in the treatment of early-stage MF is phototherapy. Full body phototherapy can be associated with photoaging of the skin and an increased risk of developing skin cancer. Targeted phototherapy, with a 308-nm excimer laser, may be just as effective and of a lower risk. This makes it especially useful in the treatment of patients with dysplastic nevi (DN) or other conditions which can put them at a higher risk of developing skin cancer. There are currently limited data on the treatment of early-stage MF with an excimer laser. Case Report: This study reports on a 43-year-old female patient presented to the clinic with early-stage (Ia) MF. Given her history of DN, she wished to pursue targeted phototherapy with an excimer laser. Localized light treatment was performed via a 308-nm excimer laser, 3 times weekly, for a total of 17 treatments to affected lesions. Following excimer laser treatment, she had a clinical resolution of her patches. On the follow-up clinic visits, she maintained her excellent response 12 months out. Conclusion: Targeted phototherapy with a 308-nm excimer laser may be a safer and equally effective alternative to generalized phototherapy in the treatment of early-stage MF. This case report demonstrates its efficacy and advantages over traditional generalized phototherapy.


Sign in / Sign up

Export Citation Format

Share Document